Market Movers

Molina Healthcare, Inc.’s stock price dips to $302.09, marking a 6.24% decline

Molina Healthcare, Inc. (MOH)

302.09 USD -20.10 (-6.24%) Volume: 1.11M

Molina Healthcare, Inc.’s stock price stands at 302.09 USD, experiencing a decline of 6.24% this trading session, with a trading volume of 1.11M. Despite today’s drop, MOH stock shows a positive year-to-date change, up by 3.79%, demonstrating its resilience in the healthcare market.


Latest developments on Molina Healthcare, Inc.

Despite losses on the day, Molina Healthcare Inc. stock has outperformed competitors, showing resilience in the market. Recent news of insiders selling US$2.7m of stock may have signaled caution to investors. This comes as Molina Healthcare, along with Encompass Health, RadNet, Evolent Health, and Ibotta shares are falling. The company’s stock price movements today reflect the challenges faced by families, as highlighted in a recent community baby shower aimed at helping new moms during these difficult times.


Molina Healthcare, Inc. on Smartkarma

Analysts on Smartkarma are closely covering Molina Healthcare, with reports from providers like Baptista Research and Value Investors Club. Baptista Research‘s report on Molina Healthcare‘s fourth-quarter and full-year 2024 results highlights both challenges and prospects for future growth. Despite an 8.5% year-over-year growth in adjusted EPS, the company faced higher-than-anticipated medical cost pressure, leading to a consolidated medical care ratio (MCR) of 90.2% for the quarter. On the other hand, Value Investors Club emphasized Molina’s successful business model in the Managed Medicaid market, where the company’s effective management of programs minimizes risk for state administrators.

Furthermore, Baptista Research‘s analysis of Molina Healthcare‘s recent earnings report for the third quarter of 2024 indicates a mixed performance. Despite reporting adjusted earnings per share of $6.01 on $9.7 billion of premium revenue, the company faced upward pressure on medical costs, resulting in a consolidated medical care ratio (MCR) of 89.2%. However, Molina Healthcare maintained a robust adjusted pre-tax margin of 4.5%, demonstrating a balanced business portfolio amidst ongoing challenges. Analysts are closely monitoring the company’s performance and the factors impacting its future growth trajectory.


A look at Molina Healthcare, Inc. Smart Scores

FactorScoreMagnitude
Value3
Dividend1
Growth4
Resilience4
Momentum4
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Molina Healthcare is positioned well for long-term growth and resilience. With high scores in Growth, Resilience, and Momentum, the company is showing positive signs of future success. While its Value score is not as high, Molina Healthcare‘s strong performance in other areas suggests that it has the potential to continue expanding and adapting to market changes.

Molina Healthcare Inc., a managed care organization specializing in health care services for low-income families, has received favorable ratings in key areas such as Growth, Resilience, and Momentum. Despite a lower score in the Dividend category, the company’s focus on providing essential health care services to Medicaid-eligible individuals positions it well for sustainable growth in the long run. With a strong presence in multiple states and primary care clinics, Molina Healthcare is poised to maintain its positive trajectory in the healthcare industry.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars